Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.
Lim SM, Park HS, Kim S, Kim S, Ali SM, Greenbowe JR, Yang IS, Kwon NJ, Lee JL, Ryu MH, Ahn JH, Lee J, Lee MG, Kim HS, Kim H, Kim HR, Moon YW, Chung HC, Kim JH, Kang YK, Cho BC.
Lim SM, et al.
Oncotarget. 2016 Mar 1;7(9):10547-56. doi: 10.18632/oncotarget.7234.
Oncotarget. 2016.
PMID: 26859683
Free PMC article.